Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC.BK)
THB 1.15
(-1.71%)
THB 1.15
(-1.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 44.11 Million | 53.51 Million | 73.6 Million | 49.89 Million | 35.13 Million | 14.18 Million |
| Net Income | 9.64 Million | 14.51 Million | 24.86 Million | 28.42 Million | 18.19 Million | 3.72 Million |
| Depreciation & Amortization | 37.08 Million | 33.5 Million | 28.98 Million | 22.27 Million | 14.76 Million | 12.46 Million |
| Deferred income taxes | 2.96 Million | 3.42 Million | 2.61 Million | 683.8 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.68 Million | -5.24 Million | 8.08 Million | -9.27 Million | -1.83 Million | -4.15 Million |
| Other non-cash items | 83.61 Million | 7.31 Million | 6.83 Million | 4.43 Million | 34.65 Million | 31.11 Million |
| Investing Cash Flow | 20.85 Million | -201.58 Million | -19.44 Million | -125.3 Million | -53.45 Million | -15.91 Million |
| Investments in PPE | -58.84 Million | -21.69 Million | -19.93 Million | -165.49 Million | -53.78 Million | -15.7 Million |
| Acquisitions | 78.97 Thousand | 16.81 Thousand | - | 45.15 Million | 13.08 Thousand | 2803.74 |
| Investment purchases | -387.93 Thousand | -180 Million | - | -5.06 Million | -11.6 Thousand | -213.38 Thousand |
| Sales/Maturities of investments | 80 Million | 666.93 Million | 429.79 Thousand | -40.09 Million | 315.54 Thousand | - |
| Other Investing Activities | -58.03 Thousand | -666.85 Million | 59.17 Thousand | 40.19 Million | 11.6 Thousand | -4.71 Million |
| Financing Cash Flow | -79.36 Million | 192.37 Million | -52.63 Million | 73.65 Million | 20.54 Million | -4.08 Million |
| Debt repayment | -3.9 Million | -118.34 Million | -42.58 Million | -36.28 Million | -13.09 Million | -8.61 Million |
| Dividends payments | -41.92 Million | -15 Million | -7.5 Million | -6 Million | -2 Million | -4 Million |
| Common Stock Repurchased | - | -12.16 Million | - | - | - | - |
| Common Stock Issuance | - | 348 Million | - | - | - | - |
| Other Financing Activities | -33.54 Million | -10.11 Million | -2.55 Million | 115.93 Million | 50 Million | 6.11 Million |
| Accounts receivables | -11.09 Million | -5.71 Million | -443.06 Thousand | -13.63 Million | -3.61 Million | -4.34 Million |
| Accounts payables | 2.73 Million | -733.89 Thousand | 7.28 Million | 2.91 Million | 1.83 Million | 2.34 Million |
| Inventory | 1.98 Million | -4.55 Million | 486.36 Thousand | -140.58 Thousand | 682.53 Thousand | -2.03 Million |
| Other working capital | 692.17 Thousand | 5.75 Million | 761.03 Thousand | 1.58 Million | -732.5 Thousand | -124.3 Thousand |
| Cash at beginning of period | 47.41 Million | 3.11 Million | 1.58 Million | 3.34 Million | 1.12 Million | 6.94 Million |
| Cash at end of period | 33.02 Million | 47.41 Million | 3.11 Million | 1.58 Million | 3.34 Million | 1.12 Million |
| Capital Expenditure | -58.84 Million | -21.69 Million | -19.93 Million | -165.49 Million | -53.78 Million | -15.7 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -14.39 Million | 44.3 Million | 1.52 Million | -1.75 Million | 2.22 Million | -5.81 Million |
| Free Cash Flow | -14.72 Million | 31.82 Million | 53.67 Million | -115.6 Million | -18.64 Million | -1.51 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.04 Million | 6.11 Million | 9.64 Million | 175.33 Thousand | 5.73 Million | 2.75 Million |
| Depreciation & Amortization | 9.96 Million | 9.81 Million | 37.08 Million | 9.87 Million | 9.6 Million | 8.94 Million |
| Deferred income taxes | 813.54 Thousand | 791.54 Thousand | 2.96 Million | 751.61 Thousand | 730.8 Thousand | 737.8 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.31 Million | 4.37 Million | -5.68 Million | 2.28 Million | -8.98 Million | 4.47 Million |
| Other non-cash items | 30.41 Million | 14.41 Million | 83.61 Million | 18.38 Million | 147.3 Thousand | 88.68 Thousand |
| Investing Cash Flow | -10.06 Million | -2.5 Million | 20.85 Million | 9.07 Million | 338.58 Thousand | -5.93 Million |
| Investments in PPE | -10.04 Million | -2.81 Million | -58.84 Million | -10.65 Million | -15.07 Million | -25.3 Million |
| Acquisitions | - | 329.9 Thousand | 78.97 Thousand | -1.00 | 16.35 Thousand | 3271.03 |
| Investment purchases | -18.95 Thousand | -18.7 Thousand | -387.93 Thousand | -346.1 Thousand | -16.35 Thousand | -13.81 Thousand |
| Sales/Maturities of investments | - | 329.9 Thousand | 80 Million | 20 Million | 10 Million | 20 Million |
| Other Investing Activities | -5.44 Million | -18.7 Thousand | -58.03 Thousand | 80 Thousand | 5.4 Million | -614.18 Thousand |
| Financing Cash Flow | -25.22 Million | -8.73 Million | -79.36 Million | -8.63 Million | -9.13 Million | -50.87 Million |
| Debt repayment | -8.86 Million | -8.73 Million | -3.9 Million | -12.53 Million | -8.43 Million | -8.21 Million |
| Dividends payments | -16.36 Million | - | -41.92 Million | -50.00 | -5465.00 | -41.91 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8.86 Million | -561.23 Thousand | -33.54 Million | 3.9 Million | -693.32 Thousand | -738.46 Thousand |
| Accounts receivables | -9.04 Million | 8.72 Million | -11.09 Million | 1.23 Million | -6.42 Million | 2.43 Million |
| Accounts payables | 1.92 Million | -3.85 Million | 2.73 Million | -3.04 Million | 5.56 Million | 3.39 Million |
| Inventory | 361.15 Thousand | -151.44 Thousand | 1.98 Million | 3.24 Million | -629.1 Thousand | 542.35 Thousand |
| Other working capital | 444.1 Thousand | -347.05 Thousand | 692.17 Thousand | 851.22 Thousand | -7.49 Million | -1.9 Million |
| Cash at beginning of period | 41.59 Million | 33.02 Million | 47.41 Million | 20.18 Million | 21.05 Million | 60.89 Million |
| Cash at end of period | 21.72 Million | 41.59 Million | 33.02 Million | 33.02 Million | 20.18 Million | 21.05 Million |
| Capital Expenditure | -10.04 Million | -2.81 Million | -58.84 Million | -10.65 Million | -15.07 Million | -25.3 Million |
| Effect of forex changes on cash | - | - | - | 1.00 | 0.77 | 0.84 |
| Net cash flow / Change in cash | -19.87 Million | 8.57 Million | -14.39 Million | 12.84 Million | -875.28 Thousand | -39.83 Million |
| Free Cash Flow | 5.37 Million | 16.99 Million | -14.72 Million | 1.74 Million | -7.15 Million | -8.34 Million |
8360
XIN
603063
1782
NETW
GIGSEK